Enanta Pharmaceuticals, Inc. (ENTA)
Market Open
26 Oct, 07:32 PM
$
11. 83
+0.19
+1.6323%
$
323.29M Market Cap
- P/E Ratio
- Div Yield
280,198 Volume
-5.15 Eps
$ 11.64
Previous Close 
Want to track ENTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enanta Pharmaceuticals, Inc. (ENTA) Statistics
Valuation metrics
Market Cap 323.29M
Enterprise value 361.26M
Trailing P/E (ttm) -4.83
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) 5.2
Price/Book (mrq) 3.35
Enterprise Value/Revenue 5.54
Enterprise Value/EBITDA -7.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 205.32K
Average volume (90 days) 236.23K
Price summary
52-Week low 10.22
52-Week high 17.15
Beta -
50-Day moving average 12.31
200-Day moving average 13.19
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.97%
Operating margin -0.9%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.24
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.51
Total debt (mrq) -
Total Debt/Equity (mrq) 0.55
Current ratio (mrq) 3.76%
Book value per share (mrq) 3.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
